EDGAR Filing Documents for 0001193125-15-063934

Form POSASR - Post-effective Amendment to an automatic shelf registration statement:

SEC Accession No. 0001193125-15-063934

Filing Date

2015-02-26

Accepted

2015-02-26 06:44:53

Documents

Effectiveness Date

2015-02-26

Document Format Files

Seq	Description	Document	Type	Size
1	POSASR	d879439dposasr.htm	POSASR	289991
2	EX-4.5	d879439dex45.htm	EX-4.5	304780
3	EX-5.1	d879439dex51.htm	EX-5.1	17768
4	EX-12.1	d879439dex121.htm	EX-12.1	29688
5	EX-23.1	d879439dex231.htm	EX-23.1	2807
6	GRAPHIC	g879439cov_pg001.jpg	GRAPHIC	4770
7	GRAPHIC	g879439ex5_1logo.jpg	GRAPHIC	8958
	Complete submission text file	0001193125-15-063934.txt		665559

Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142

Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000

Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)